MORGAN STANLEY - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$10,931,298
-13.3%
608,986
-1.9%
0.00%0.0%
Q2 2023$12,603,046
+24.3%
620,534
+11.6%
0.00%0.0%
Q1 2023$10,142,919
-10.2%
556,081
+1.8%
0.00%0.0%
Q4 2022$11,298,499
+22.3%
546,349
+54.7%
0.00%0.0%
Q3 2022$9,236,000
-37.6%
353,061
-39.5%
0.00%
-50.0%
Q2 2022$14,791,000
+87.0%
583,696
+132.9%
0.00%
+100.0%
Q1 2022$7,910,000
-86.4%
250,630
-82.5%
0.00%
-85.7%
Q4 2021$58,049,000
+1143.8%
1,434,404
+971.9%
0.01%
+600.0%
Q3 2021$4,667,000
-36.9%
133,813
-50.3%
0.00%0.0%
Q2 2021$7,399,000
+50.9%
269,458
+54.3%
0.00%0.0%
Q1 2021$4,902,000
+299.5%
174,596
+269.4%
0.00%
Q4 2020$1,227,000
+148.4%
47,262
+64.0%
0.00%
Q3 2020$494,000
-78.2%
28,826
-68.5%
0.00%
-100.0%
Q2 2020$2,265,000
+4933.3%
91,582
+2725.7%
0.00%
Q1 2020$45,000
-90.0%
3,241
-92.8%
0.00%
Q4 2019$452,000
+361.2%
44,736
+314.3%
0.00%
Q3 2019$98,000
-87.5%
10,797
-89.1%
0.00%
Q2 2019$785,000
+528.0%
98,806
+879.2%
0.00%
Q1 2019$125,000
-77.2%
10,090
-80.2%
0.00%
Q4 2018$549,000
+149.5%
50,936
+223.5%
0.00%
Q3 2018$220,000
+50.7%
15,744
+31.8%
0.00%
Q2 2018$146,000
+57.0%
11,943
+99.0%
0.00%
Q1 2018$93,0006,0030.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$65,241,00019.83%
Octagon Capital Advisors LP 2,095,231$84,794,00016.50%
EcoR1 Capital, LLC 5,523,358$223,530,0007.12%
BVF INC/IL 3,398,067$137,520,0004.99%
PFM Health Sciences, LP 3,431,010$138,853,0004.73%
Alphabet Inc. 2,563,441$103,742,0002.50%
Boxer Capital, LLC 1,432,200$57,961,0002.25%
PARK CIRCLE Co 64,000$2,590,0002.04%
SECTORAL ASSET MANAGEMENT INC 283,210$11,462,0001.72%
DAFNA Capital Management LLC 117,200$4,743,0001.19%
View complete list of ARCUS BIOSCIENCES INC shareholders